NRC Health (NRC)

NRC Health Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 3, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	440	425	407	958	919	1,053
Market Cap Growth	52.86%	4.35%	-57.50%	4.30%	-12.76%	-2.99%
Enterprise Value	518.64	499.8	465.64	988.17	915.79	1,025
Last Close Price	19.87	18.77	17.64	39.56	37.30	41.52

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 3, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	81.16	37.54	16.96	31.65	29.37	28.44
Forward PE	20.54	34.39	34.39	34.39	34.39	34.39
PEG Ratio	-	2.93	2.93	2.93	2.93	2.93
PS Ratio	3.09	3.09	2.85	6.45	6.06	7.12
PB Ratio	65.95	30.37	13.02	19.57	12.75	12.34
P/TBV Ratio	-	-	-	-	106.09	48.54
P/FCF Ratio	19.96	26.99	21.23	42.90	34.76	25.79
P/OCF Ratio	14.64	16.06	11.76	25.14	25.33	22.72

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 3, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	3.70	3.64	3.25	6.65	6.04	6.93
EV/EBITDA Ratio	22.19	16.54	11.30	21.51	17.67	18.10
EV/EBIT Ratio	35.19	22.12	13.23	24.68	19.68	20.39
EV/FCF Ratio	23.97	31.75	24.28	44.25	34.65	25.11

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 3, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	13.13	5.36	1.85	0.60	0.25	0.26
Debt / EBITDA Ratio	3.85	2.62	1.52	0.80	0.43	0.47
Debt / FCF Ratio	4.16	5.02	3.27	1.64	0.84	0.65
Net Debt / Equity Ratio	13.24	5.35	1.87	0.61	-0.04	-0.33
Net Debt / EBITDA Ratio	3.71	2.48	1.42	0.65	-0.05	-0.49
Net Debt / FCF Ratio	4.01	4.76	3.05	1.35	-0.11	-0.68
Asset Turnover	1.03	1.03	1.12	1.18	1.05	1.02
Quick Ratio	0.36	0.43	0.43	0.53	1.20	1.70
Current Ratio	0.65	0.55	0.55	0.67	1.31	1.82
Return on Equity (ROE)	57.05%	51.24%	61.77%	51.20%	40.41%	50.07%
Return on Assets (ROA)	6.79%	10.98%	20.93%	24.54%	24.01%	26.63%
Return on Invested Capital (ROIC)	10.10%	16.44%	31.63%	41.89%	54.56%	65.79%
Return on Capital Employed (ROCE)	14.78%	23.18%	38.48%	43.70%	43.46%	45.93%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 3, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	1.28%	2.66%	5.90%	3.16%	3.40%	3.52%
FCF Yield	5.01%	3.71%	4.71%	2.33%	2.88%	3.88%
Dividend Yield	3.28%	2.61%	2.74%	3.75%	2.25%	0.87%
Payout Ratio	266.23%	94.64%	46.21%	117.42%	65.92%	24.45%
Buyback Yield / Dilution	5.38%	5.67%	3.77%	1.51%	2.29%	0.22%
Total Shareholder Return	8.66%	8.29%	6.51%	5.26%	4.55%	1.09%

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Jul 28, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 3, 2026

Data Sources Report a data error